DiaSorin Simplexa COVID & Flu A/B Assay Gets FDA Clearance
DiaSorin received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Simplexa COVID & Flu A/B Direct assay.
Read MorePosted by Andy Lundin | Mar 21, 2023 | Covid 19 |
DiaSorin received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Simplexa COVID & Flu A/B Direct assay.
Read MorePosted by Chris Wolski | Mar 21, 2023 | Molecular Diagnostic Analyzers |
Pharyngitis testing and diagnosis can be improved by utilizing existing molecular testing capacity increased due to COVID.
Read MorePosted by Andy Lundin | Mar 20, 2023 | Emerging & Zoonotic Diseases |
Cue Health has received EUA from the U.S. Food and Drug Administration (FDA) for its molecular test to detect the mpox (monkeypox) virus.
Read MorePosted by Andy Lundin | Mar 17, 2023 | Company News, Lab Automation |
INTEGRA Biosciences acquired Miroculus, a biotechnology specialist focused on developing hands-off automation solutions for NGS protocols.
Read MorePosted by Chris Wolski | Mar 17, 2023 | Covid 19, Sequencing Systems |
Though not a new diagnostic technique, multiplex testing is poised to become the standard of diagnostic care in the post-pandemic world.
Read More